2024-03-29T06:16:08Z
https://soar-ir.repo.nii.ac.jp/oai
oai:soar-ir.repo.nii.ac.jp:00006926
2023-02-13T01:07:00Z
461:463:805:813
フイブリノゲンγ鎖における遺伝子多型の検討
Studies on Genetic Polymorphism in Human Fibrinogen Gamma Chain
寺澤, 文子
奥村, 伸生
降旗, 謙一
Fibrinogen
Gamma Chain
Genetic Polymorphism
DNA Sequence
フィブリノゲン
γ鎖
遺伝子多型
DNA塩基配列
In the gene of human fibrinogen gamma chain, nucleotide poly(di)morphism has been reported at eight different positions. Among them, nucleotide 2543 is the middle base of the codon which encords residue 88 resulting in an amino acid substitution of Lysine to lsoleucine. However remaining seven mutations are silent. We examined frequency of genomic polymorphism for gamma chain nucleotide 2543 by DNA sequencing and effect of the amino acid substitution on fibrinogen function. DNA was isolated from peripheral nucleated cells of 11healthy volunteers and one patient with dysfibrinogenemia and the fourth exon of gamma chain containing the nucleotide 2543 was amplified by polymerase chain reaction(PCR). Nucleotide sequence was directry analyzed by Dye Deoxy Terminator method using an ABI 373A DNA sequencer. The nucleotide 2543 was A in all 12 samples. We investigated gamma chain sequence of a case of dysfibrinogenemia and found that the nucleotide 2543 was homozygous for A but heterozygous for G and C at nucleotide 9380, resulted in the substitution of Aspartic acid and Histidine. We conclude that Lysine at residue 88 of gamma chain is wild type and lsoleucine is a rare mutation. It was also suggested that this polymorphism was not responsible for the pathogenesis of the dysfibrinogenemia.
Article
紀要 20: 31-36(1995)
departmental bulletin paper
信州大学医療技術短期大学部
1995-02-28
application/pdf
紀要
20
31
36
0385-1982
AN10402438
https://soar-ir.repo.nii.ac.jp/record/6926/files/Allied_Med20_05.pdf
jpn